碳酸锂
碳酸锂用途
用于半导体、电视机、原子能、陶瓷、医药、催化剂等部门，也用于制取锂化合物
【用途二】
主要用于制作钽酸锂、铌酸锂等声学级单晶、光学级单晶等
【用途三】
用于制取锂化合物、锂材料等
【用途四】
用于锂化合物及搪瓷、玻璃制造，医药上用作治疗狂躁抑郁性精神病药物
【用途五】
用于制取声学级单晶，光学级单晶。也是制取高纯锂化合物和金属锂的原料。
【用途六】
是制取锂化合物和金属锂的原料。可作铝冶炼的电解浴添加剂。在玻璃、陶瓷、医药和食品等工业中应用广泛，亦可用于合成橡胶、染料、半导体及军事国防工业等方面。
【用途七】
用于治疗狂燥性精神病，制作镇静剂等。
【用途八】
制取各种高纯锂盐的原料,铌酸锂、碳酸锂单晶的制备原材料,用于光学特种玻璃,搪瓷工业,医药,催化剂,彩色荧光粉及锂离子电池材料等.
碳酸锂名称
[ CAS 号 ]:
554-13-2
[ 中文名 ]:
碳酸锂
[ 英文名 ]:
Lithium carbonate
[中文别名 ]:
[英文别名 ]:
- Priadel
- Limas
- Lithea
- Eutimin
- Plenur
- Lithium carbonate
- MFCD00134051
- Litard
- EINECS 209-062-5
- Liticar
碳酸锂物理化学性质
[ 密度 ]:
2.11 g/mL at 25 °C
[ 沸点 ]:
1342 °C(lit.)
[ 熔点 ]:
720 °C
[ 分子式 ]:
CLi2O3
[ 分子量 ]:
73.891
[ 闪点 ]:
1310°C
[ 精确质量 ]:
74.016754
[ PSA ]:
63.19000
[ 外观性状 ]:
白色粉末
[ 储存条件 ]:
室温
[ 水溶解性 ]:
13 g/L (20 ºC)
碳酸锂MSDS
碳酸锂毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- OJ5800000
- CAS REGISTRY NUMBER :
- 554-13-2
- LAST UPDATED :
- 199801
- DATA ITEMS CITED :
- 60
- MOLECULAR FORMULA :
- C-O3.2Li
- MOLECULAR WEIGHT :
- 73.89
- WISWESSER LINE NOTATION :
- LI2 C-O3
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 25 gm/kg/4Y-I
- TOXIC EFFECTS :
- Behavioral - tremor Sense Organs and Special Senses (Eye) - miosis (pupillary constriction)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 612 mg/kg/44D-I
- TOXIC EFFECTS :
- Behavioral - sleep Skin and Appendages - dermatitis, allergic (after systemic exposure)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 8 mg/kg
- TOXIC EFFECTS :
- Gastrointestinal - nausea or vomiting Skin and Appendages - dermatitis, other (after systemic exposure)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 8760 mg/kg/2Y-I
- TOXIC EFFECTS :
- Endocrine - thyroid weight (goiter) Endocrine - evidence of thyroid hyperfunction
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 4111 mg/kg
- TOXIC EFFECTS :
- Behavioral - tremor Behavioral - muscle weakness Gastrointestinal - other changes
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 54 mg/kg
- TOXIC EFFECTS :
- Behavioral - sleep Behavioral - hallucinations, distorted perceptions
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 120 mg/kg/10D-I
- TOXIC EFFECTS :
- Behavioral - excitement
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 1080 mg/kg/13W-I
- TOXIC EFFECTS :
- Skin and Appendages - dermatitis, allergic (after systemic exposure)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 556 mg/kg/32D
- TOXIC EFFECTS :
- Behavioral - toxic psychosis
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 525 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression Gastrointestinal - hypermotility, diarrhea
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 156 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - respiratory depression Gastrointestinal - hypermotility, diarrhea
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 434 mg/kg
- TOXIC EFFECTS :
- Sense Organs and Special Senses (Eye) - lacrimation Lungs, Thorax, or Respiration - respiratory depression Skin and Appendages - hair
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 241 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Lungs, Thorax, or Respiration - respiratory depression
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 531 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 236 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Behavioral - excitement Behavioral - ataxia
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 413 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 497 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Lungs, Thorax, or Respiration - respiratory depression
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 4500 mg/kg/30D-I
- TOXIC EFFECTS :
- Nutritional and Gross Metabolic - weight loss or decreased weight gain Nutritional and Gross Metabolic - dehydration Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 18200 mg/kg/26W-I
- TOXIC EFFECTS :
- Endocrine - changes in adrenal weight Nutritional and Gross Metabolic - weight loss or decreased weight gain Nutritional and Gross Metabolic - weight loss or decreased weight gain
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 36400 mg/kg/52W-I
- TOXIC EFFECTS :
- Cardiac - changes in heart weight Gastrointestinal - other changes Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 3600 mg/kg/21W-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Blood - leukemia
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 21 gm/kg/3.5Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Endocrine - thyroid tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 5940 mg/kg/47W-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Blood - leukemia
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 6132 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Blood - leukemia
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 3072 mg/kg
- SEX/DURATION :
- female 1-37 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4900 mg/kg
- SEX/DURATION :
- female 1-35 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4256 mg/kg
- SEX/DURATION :
- female 1-38 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - Apgar score (human only) Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 10080 mg/kg
- SEX/DURATION :
- female 26 week(s) pre-mating - 34 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - stillbirth
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- DOSE :
- 540 mg/kg
- SEX/DURATION :
- female 35-39 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- DOSE :
- 556 mg/kg
- SEX/DURATION :
- female 30-34 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- DOSE :
- 11520 mg/kg
- SEX/DURATION :
- female 7 week(s) pre-mating female 1-38 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - gastrointestinal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- DOSE :
- 11520 mg/kg
- SEX/DURATION :
- female 7 week(s) pre-mating female 1-38 week(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - Apgar score (human only) Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 600 mg/kg
- SEX/DURATION :
- female 9-14 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1 gm/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1050 mg/kg
- SEX/DURATION :
- female 1-21 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 1050 mg/kg
- SEX/DURATION :
- lactating female 21 day(s) post-birth
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4650 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 4650 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 2 gm/kg
- SEX/DURATION :
- female 8-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - live birth index (measured after birth)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 600 mg/kg
- SEX/DURATION :
- female 7-12 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Newborn - sex ratio
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 40 mg/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 200 mg/kg
- SEX/DURATION :
- female 9 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - musculoskeletal system
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- DOSE :
- 300 mg/kg
- SEX/DURATION :
- female 8 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Unreported
- DOSE :
- 4650 mg/kg
- SEX/DURATION :
- female 6-15 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 240 gm/kg
- SEX/DURATION :
- female 36-115 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 240 gm/kg
- SEX/DURATION :
- female 36-115 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Newborn - other neonatal measures or effects
- TYPE OF TEST :
- Cytogenetic analysis
- TYPE OF TEST :
- DNA inhibition
- TYPE OF TEST :
- Cytogenetic analysis
- TYPE OF TEST :
- Sister chromatid exchange
MUTATION DATA
- TYPE OF TEST :
- Mutation in mammalian somatic cells
- TEST SYSTEM :
- Rodent - hamster Lung
- DOSE/DURATION :
- 2 gm/L
- REFERENCE :
- MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 169,171,1986 *** REVIEWS *** TOXICOLOGY REVIEW DICPBB Drug Intelligence and Clinical Pharmacy. (POB 42435, Cincinnati, OH 45242) V.3- 1969- Volume(issue)/page/year: 8,690,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84414 No. of Facilities: 1035 (estimated) No. of Industries: 8 No. of Occupations: 10 No. of Employees: 6333 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X6906 No. of Facilities: 3 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 198 (estimated) No. of Female Employees: 151 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84414 No. of Facilities: 2182 (estimated) No. of Industries: 17 No. of Occupations: 31 No. of Employees: 39147 (estimated) No. of Female Employees: 17568 (estimated)
碳酸锂安全信息
[ 符号 ]:
GHS07
[ 信号词 ]:
Warning
[ 危害声明 ]:
H302-H319
[ 警示性声明 ]:
P301 + P312 + P330-P305 + P351 + P338
[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves
[ 危害码 (欧洲) ]:
Xn:Harmful;
[ 风险声明 (欧洲) ]:
R22;R36/37/38;R41
[ 安全声明 (欧洲) ]:
S8-S43-S45-S37/39-S26-S36/37-S24/25
[ 危险品运输编码 ]:
UN 3264 8/PG 3
[ WGK德国 ]:
2
[ RTECS号 ]:
OJ5800000
[ 海关编码 ]:
2836910000
碳酸锂合成路线
碳酸锂上下游产品
碳酸锂上游产品
碳酸锂下游产品
碳酸锂制备
１．卤水综合利用法卤水经提取氯化钡后的含锂料液加入纯碱以除去料液内钙、镁离子，加入盐酸酸化，蒸发去除氯化钠，再经除铁，然后加入过量纯碱使碳酸锂沉淀，经水洗、离心分离、干燥，制得碳酸锂成品。其反应式如下：
２．石灰烧结法锂辉石精矿（一般含氧化锂6％）和石灰石按1∶（2.5～3）重量比配料。混合磨细，在1150～1250 ℃下烧结生成铝酸锂和硅酸钙，经湿磨粉碎，用洗液浸出氢氧化锂，经沉降过滤，滤渣返回或洗涤除渣，浸出液经蒸发浓缩，然后加入碳酸钠生成碳酸锂，再经离心分离、干燥，制得碳酸锂成品。其反应式如下：
3.用氢氧化锂和二氧化碳为原料反应便可制得高纯度的碳酸锂，也可以用硫酸锂和碳酸钠为反应物，但碳酸锂易溶于其他盐溶液中，故产率不太高，一般为75%左右，而且产物中还会含有少量的硫酸锂。
精制法［13］称取25g碳酸锂，在室温下搅拌溶于2L水中，过滤除去不溶物质，激烈搅拌防止碳酸锂粘在烧杯壁上，慢慢加热至接近沸点，至完全沉淀，趁热过滤，再用沸水洗涤碳酸锂2～3次，在110℃下干燥，将滤液冷却，加入碳酸锂直至饱和，重复以上操作，可制得与第一次纯度基本相同的产物。
4.硫酸法 将熔融的锂辉石与硫酸反应，经净化后再与碳酸钠反应制得。石灰法 将焙烧的锂辉石与石灰乳反应，经净化后再与碳酸钠反应制得。副产法 由井盐卤制氯化钡后含锂的母液中提取。
5.以工业氢氧化锂为原料，加热水将其溶解后，滤去不溶物，趁热向滤液中通入干净二氧化碳气体至不再生成沉淀为止：
趁热过滤，甩干，用热蒸馏水洗涤至合格，于110℃烘干即可。将工业碳酸锂溶于冷水中，过滤后，滤液煮沸，停止加热，趁热过滤，热水洗涤、甩干、干燥，也能制得试剂碳酸锂。
碳酸锂海关
[ 海关编码 ]: 2836910000
碳酸锂文献
PLoS ONE 10(1) , e0116566, (2015)
Upregulation and/or maintenance of regulatory T cells (Tregs) during an autoimmune insult may have therapeutic efficacy in autoimmune diseases. Although several immunomodulatory drugs and molecules ar...
Gene expression profiling of peri-implant healing of PLGA-Li+ implants suggests an activated Wnt signaling pathway in vivo.PLoS ONE 9(7) , e102597, (2014)
Bone development and regeneration is associated with the Wnt signaling pathway that, according to literature, can be modulated by lithium ions (Li+). The aim of this study was to evaluate the gene exp...
Evaluation of an electrochemical biosensor for uric acid measurement in human whole blood samples.Clin. Chim. Acta 436 , 72-7, (2014)
Uric acid measurement has become increasingly important, and electrochemically modified detection method based portable devices hold a dominant position in the market for point of care and self-monito...
相关化工产品/化学物质：
推荐生产厂家/供应商：
公司名：上海化源世纪贸易有限公司
区域：上海市普陀区
价格：
联系人：徐乾明
产品详情：碳酸锂
公司名：南通润丰石油化工有限公司
区域：南通市崇川区
价格：
￥需询单/1kg
￥需询单/1ton
联系人：曹经理
产品详情：碳酸锂
公司名：上海吉至生化科技有限公司
区域：上海市奉贤区
价格：
￥88.0/100g
￥248.0/500g
联系人：刘佳
产品详情：碳酸锂
公司名：上海脉铂医药科技有限公司
区域：上海市嘉定区
价格：
￥1689.0/500g
￥489.0/1g
￥489.0/100g
￥需询单/1g
联系人：李先生
产品详情：Lithium carbonate
公司名：上海阿拉丁生化科技股份有限公司
区域：上海市浦东新区
价格：
￥29.9/5g
￥109.9/25g
￥205.9/1ml
￥159.9/100g
联系人：阿拉丁
产品详情：碳酸锂
查看所有供应商请点击：
相关化合物
【碳酸锂】化源网提供碳酸锂CAS号554-13-2，碳酸锂MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询碳酸锂上化源网，专业又轻松。>>电脑版：碳酸锂
标题：碳酸锂_MSDS_用途_密度_碳酸锂CAS号【554-13-2】_化源网 地址：https://www.chemsrc.com/amp/cas/554-13-2_829434.html